TRILC Turk Ilac Ve Serum Sanayi Anonim Sirketi

BIST · TR · Healthcare · Drug Manufacturers - Specialty & Generic · turkilac.com.tr

0.7900TRY+2.60%Mkt Cap: 19.09M $P/E: —Today

Turk Ilac Ve Serum Sanayi Anonim Sirketi produces and sells human tablets, capsules, ampoules, vials, ointments-creams, intravenous serums, parenteral solutions, nutritional solutions, amino acids, and other chemicals in…

Industry Peers

Drug Manufacturers - Specialty & Generic

Screen all

MRK

MERCK Kommanditgesellschaft auf Aktien

$64.70BUSDP/E 25.1

TAK

Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock)

$57.06BUSD

TEVA

Teva Pharmaceutical Industries Limited Ordinary Shares

$46.10BUSDP/E 65.9

HLN

Haleon plc American Depositary Shares (Each representing two Ordinary Shares)

$38.70BUSDP/E 18.3

ZTS

Zoetis Inc. Class A Common Stock

United Therapeutics Corporation - Common Stock

$23.23BUSDP/E 19.4

VTRS

Viatris Inc. - Common Stock

$20.22BUSD

SOBI

Swedish Orphan Biovitrum AB

$14.24BUSDP/E 109.4

NBIX

Neurocrine Biosciences, Inc. - Common Stock

Elanco Animal Health Incorporated Common Stock

$11.06BUSD

RDY

Dr. Reddy's Laboratories Ltd Common Stock

Amneal Pharmaceuticals, Inc. - Class A Common Stock

$7.07BUSDP/E 42.3

ALKS

Alkermes plc - Ordinary Shares

$7.00BUSDP/E 109.9

HIMS

Hims & Hers Health, Inc. Class A Common Stock

$6.77BUSD

LNTH

Lantheus Holdings, Inc. - Common Stock

$6.53BUSDP/E 23.9

KNSA

Kiniksa Pharmaceuticals International, plc - Class A Ordinary Shares

$5.83BUSDP/E 76.6

HIK

Hikma Pharmaceuticals PLC

$4.19BUSDP/E 11.9

Key Statistics

Company

Market Cap19.09M USD

Enterprise Value116.61M USD

Revenue (TTM)121.64M USD

Gross Profit19.17M USD

Net Income (TTM)1.73M USD

Revenue/Share4.91 TRY

Last Price0.7900 TRY

Fiscal Year EndDec 2025

MR QuarterMar 2026

Employees689

CountryTR

SectorHealthcare

IndustryDrug Manufacturers - Specialty & Generic

ISIN—

Valuation

P/E (Trailing)—

P/E (Forward)—

PEG—

EV/EBITDA3.59

EV/Revenue0.96

P/S0.16

P/B0.40

EPS (TTM)-0.47

EPS (Forward)—

52W Range

0.71002% of range4.400

52W High4.400 TRY

52W Low0.7100 TRY

Profitability

Gross Margin31.22%

Oper. Margin20.40%

EBITDA Margin26.71%

Profit Margin2.82%

ROE3.76%

ROA1.81%

Growth

Revenue Growth65.10%

Earnings Growth—

Cash Flow & Leverage

Operating CF-9.05M USD

CapEx (TTM)3.63M USD

FCF Margin-58.73%

FCF Yield-374.11%

Net Debt97.52M USD

Net Debt/EBITDA3.00

Balance Sheet

Debt/Equity0.86

Current Ratio0.99

Quick Ratio0.49

Book Value/Sh1.92 TRY

Cash/Share0.04 TRY

Dividends

Fwd Div Rate—

Trail. Div Rate0.00 TRY

Div. Yield0.00%

5Y Avg Yield—

Payout Ratio0.00%

Ex-Div Date—

Pay Date—

Splits

Last Split640.8949:100

Split DateApr 27, 2026

Analyst Consensus

Rating—

Target (Mean)—

Target Range—

# Analysts—

Ownership

Shares Out.1.04B

Float368.77M

Insiders26.76%

Institutions0.07%

Technical

SMA 501.073 (-26.4%)

SMA 2002.077 (-62.0%)

Beta0.19

S&P 52W Chg14.58%

Avg Vol (30d)3.72M

Avg Vol (10d)3.45M

Technical Indicators

RSI (14)23.8

MACD-0.0960

MACD Signal-0.0806

MACD Hist.-0.0155

BB Upper1.167 TRY

BB Middle0.9415 TRY

BB Lower0.7159 TRY

BB Width47.91%

ATR (14)0.0365 TRY

Vol Ratio (20d)0.87x